[go: up one dir, main page]

DE69932817D1 - Reinigungsverfahren zur herstellng von mannan bindendem lectin (mbl) und mbl enthaltende medizinische zubereitung - Google Patents

Reinigungsverfahren zur herstellng von mannan bindendem lectin (mbl) und mbl enthaltende medizinische zubereitung

Info

Publication number
DE69932817D1
DE69932817D1 DE69932817T DE69932817T DE69932817D1 DE 69932817 D1 DE69932817 D1 DE 69932817D1 DE 69932817 T DE69932817 T DE 69932817T DE 69932817 T DE69932817 T DE 69932817T DE 69932817 D1 DE69932817 D1 DE 69932817D1
Authority
DE
Germany
Prior art keywords
mbl
product
virus
manufacture
cleaning procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69932817T
Other languages
English (en)
Other versions
DE69932817T2 (de
Inventor
Inga Laursen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Statens Serum Institut SSI
Original Assignee
Statens Serum Institut SSI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Serum Institut SSI filed Critical Statens Serum Institut SSI
Publication of DE69932817D1 publication Critical patent/DE69932817D1/de
Application granted granted Critical
Publication of DE69932817T2 publication Critical patent/DE69932817T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726Lectins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
DE69932817T 1998-06-10 1999-06-10 Reinigungsverfahren zur herstellng von mannan bindendem lectin (mbl) und mbl enthaltende medizinische zubereitung Expired - Lifetime DE69932817T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DK79398 1998-06-10
DK79398 1998-06-10
US10100798P 1998-09-18 1998-09-18
US101007P 1998-09-18
PCT/DK1999/000319 WO1999064453A1 (en) 1998-06-10 1999-06-10 Purification process for production of mannan-binding lectin and an mbl medicinal product

Publications (2)

Publication Number Publication Date
DE69932817D1 true DE69932817D1 (de) 2006-09-28
DE69932817T2 DE69932817T2 (de) 2007-03-15

Family

ID=26064673

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69932817T Expired - Lifetime DE69932817T2 (de) 1998-06-10 1999-06-10 Reinigungsverfahren zur herstellng von mannan bindendem lectin (mbl) und mbl enthaltende medizinische zubereitung

Country Status (9)

Country Link
EP (1) EP1084143B1 (de)
AT (1) ATE336504T1 (de)
AU (1) AU764066B2 (de)
CA (1) CA2334696C (de)
DE (1) DE69932817T2 (de)
DK (1) DK1084143T3 (de)
ES (1) ES2272067T3 (de)
NZ (1) NZ509089A (de)
WO (1) WO1999064453A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100497849B1 (ko) 1997-08-21 2005-06-29 다카라 바이오 가부시키가이샤 제암제
AU781135B2 (en) * 1999-05-14 2005-05-05 Thomas Vorup Jensen Recombinant human mannan-binding lectin
US7387993B2 (en) * 2000-07-13 2008-06-17 Natimmune A/S Mannan-binding lectin (MBL) treatment of infections in individuals treated with TNF-αinhibitors
EP1412377A1 (de) 2001-07-23 2004-04-28 Natimmune A/S Herstellung von hochmolekularen lectinen
WO2003018617A1 (en) * 2001-08-31 2003-03-06 Fuso Pharmaceutical Industries, Ltd. Method of purifying human mannose binding lectin, human mannose binding lectin compositions and medicinal use of human mannose binding lectin
ES2271515T3 (es) * 2002-03-15 2007-04-16 Natimmune A/S Composiciones farmaceuticas que comprenden lecitina de union a manosa.
EP1501537A4 (de) * 2002-04-24 2008-01-16 Queensland Inst Med Res Mannose bindendes lectin und seine verwendungszwecke
GB0222014D0 (en) * 2002-09-23 2002-10-30 Leuven K U Res & Dev Mannan-binding lectin
WO2006035024A1 (en) * 2004-09-29 2006-04-06 Mellitus, S.L. Method for detecting a predisposition to develop gestational diabetes mellitus and treatment for this disease
WO2006042541A1 (en) * 2004-10-21 2006-04-27 Statens Serum Institut A method comprising nanofiltration to obtain an mbl product safe from infectious agents and the product obtainable by this method
WO2007095154A2 (en) * 2006-02-10 2007-08-23 The Brigham And Women's Hospital, Inc. Lectin complement pathway assays and related compositions and methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270199A (en) * 1987-08-20 1993-12-14 The Children's Medical Center Corporation Human mannose-binding protein

Also Published As

Publication number Publication date
DK1084143T3 (da) 2006-12-27
AU4134399A (en) 1999-12-30
NZ509089A (en) 2002-10-25
CA2334696A1 (en) 1999-12-16
ATE336504T1 (de) 2006-09-15
CA2334696C (en) 2014-03-25
ES2272067T3 (es) 2007-04-16
DE69932817T2 (de) 2007-03-15
EP1084143B1 (de) 2006-08-16
AU764066B2 (en) 2003-08-07
EP1084143A1 (de) 2001-03-21
WO1999064453A1 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
Zocchi et al. A single protein immunologically identified as CD38 displays NAD+ glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities at the outer surface of human erythrocytes
Valenzuela et al. Purification, cloning, and expression of a novel salivary anticomplement protein from the tick, Ixodes scapularis
Acquah et al. Structure‐informed separation of bioactive peptides
UA48105C2 (uk) ФРАГМЕНТ ДНК, ЯКИЙ КОДУЄ БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), РЕКОМБІНАНТНА МОЛЕКУЛА ДНК (ВАРІАНТИ), КЛІТИНА-ХАЗЯЇН (ВАРІАНТИ), СПОСІБ ОДЕРЖАННЯ БІЛКУ РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ (ВАРІАНТИ), АНТИТІЛО АБО ФРАГМЕНТ АНТИТІЛА (ВАРІАНТИ), МОЛЕКУЛА КДНК (ВАРІАНТИ)
DE69932817D1 (de) Reinigungsverfahren zur herstellng von mannan bindendem lectin (mbl) und mbl enthaltende medizinische zubereitung
US4228154A (en) Purification of plasma albumin by ion exchange chromatography
HUP0103758A2 (hu) Neurotróf faktorok
JP2002302500A (ja) 新規蛋白質及びこれを使用した薬剤の製法
AU1618000A (en) Use of radioligands to screen inhibitors of amyloid-beta peptide production
RU93045577A (ru) Слитные полипептиды
EP0375438A3 (de) Rekombinante DNS-Moleküle, Wirte, Verfahren und proteinartige menschliche Somatomedinträger-Polypeptide
DE69926226D1 (de) Neues verfahren zur trennung von proteinen unter verwendung eines ca++ enthaltenden elutionsmittels
ATE323766T1 (de) Glykosylierte leptinzusammensetzungen und zugehörige verfahren
WO2002101021A3 (en) Purification of human serum albumin
Schrimsher et al. Characterization of human and mouse granulocyte-macrophage-colony-stimulating factors derived from Escherichia coli
Kenig et al. Identification of the heparin-binding domain of TNF-alpha and its use for efficient TNF-alpha purification by heparin–Sepharose affinity chromatography
WO2004042083A3 (en) Nucleic acid ligands and uses therefor
KR101414897B1 (ko) 다베포에틴 알파의 정제 방법
CA2002833A1 (en) Interferon-gamma binding proteins
Ueda et al. Ni (II)-based immobilized metal ion affinity chromatography of recombinant human prolactin from periplasmic Escherichia coli extracts
DE69125381D1 (de) Proteinstruktur des pflanzlichen toxins gelonin
WO2002004487A3 (de) Verfahren zur gewinnung und anwendung neuer humaner defensine als biologisch aktive eiweisstoffe zur behandlung von infektionen und anderen erkrankungen
Romero et al. Purification and amino acid sequence of aminopeptidase P from pig kidney
AU1417999A (en) Chemokine alpha-5
WO2000047723A3 (en) Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same

Legal Events

Date Code Title Description
8364 No opposition during term of opposition